Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 25, 16:00
536.20
-2.5 (-0.46%)
VOLUME 2,478
LIVE
NSE
Mar 25, 15:46
536.90
-3.35 (-0.62%)
VOLUME 11,060
News on Alembic Pharmaceuticals
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Alembic Pharma gets USFDA nod for conjunctivitis treatment drug

11.54 am | 22 Mar 2019 |  Source: PTI

The approved product is therapeutically equivalent to the reference listed drug Optivar Ophthalmic Solution of Mylan Specialty L P....

Volume shockers: Alembic Pharma, KPIT Tech among 5 stocks that are moving the most

2.25 pm | 18 Feb 2019 |  Source: Moneycontrol.com

From the BSE, the stocks which moved the most with respect to volume included names like Alembic Pharma, Goodyear, KPIT Tech and Thermax....

Alembic Pharma gets USFDA nod for ophthalmic solution

11.15 am | 15 Feb 2019 |  Source: PTI

The approved product is therapeutically equivalent to the reference listed drug product Vigamox Ophthalmic Solution USP, 0.5 per cent, of Novartis Pha...

Alembic Pharmaceuticals rises 3% on USFDA approval for Fenofibrate tablets

11.11 am | 13 Feb 2019 |  Source: Moneycontrol.com

The company's wholly owned step down subsidiary Orit Laboratories LLC has received USFDA approval for Fenofibrate tablets USP....

Hold Alembic Pharma; target of Rs 620: ICICI Direct

4.07 pm | 25 Jan 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated January 23, 2019....

Alembic Pharma Q3 profit up 30% to Rs 170 cr

4.56 pm | 22 Jan 2019 |  Source: PTI

The company had posted a net profit of Rs 130.60 crore in the year-ago period, Alembic Pharma said in a filing to BSE....

Alembic Pharma Consolidated December 2018 Net Sales at Rs 1,018.15 crore, Up 21.21% Y-o-Y.

2.47 pm | 22 Jan 2019 |  Source: Moneycontrol.com

NULL...

Alembic Pharma Standalone December 2018 Net Sales at Rs 904.72 crore, up 19.84% Y-o-Y

2.47 pm | 22 Jan 2019 |  Source: Moneycontrol.com

NULL...

Alembic Pharma Q3 PAT seen up 7.7% YoY to Rs. 140.6 cr: ICICI Direct

5.07 pm | 11 Jan 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 21.4 percent Y-o-Y (down 9.5 percent Q-o-Q) to Rs. 1019.5 crore, according to ICICI Direct....

Hold Alembic Pharma; target of Rs 560: ICICI Direct

3.59 pm | 24 Oct 2018 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018....

Alembic Pharma Q2 profit up 64% to Rs 200 cr

3.01 pm | 22 Oct 2018 |  Source: PTI

The company had posted a net profit of Rs 121.56 crore in the year-ago period, Alembic Pharma said in a filing to BSE....

Alembic Pharma Q2 PAT may dip 9.3% YoY to Rs. 110 cr: HDFC Securities

6.17 pm | 17 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 18.8 percent Y-o-Y (up 8.7 percent Q-o-Q) to Rs. 940 crore, according to HDFC Securities....

Alembic Pharma Q2 PAT may dip 4.5% YoY to Rs. 116.1 cr: ICICI Direct

3.34 pm | 12 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 20.7 percent Y-o-Y (up 10.4 percent Q-o-Q) to Rs. 952.3 crore, according to ICICI Direct....

1 2
Quick Links for Alembic Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.